MolNFT v1 · #122337 · protein
Tobacco 5-epi-aristolochene synthase without buffer molecule in the active site
5IM1: “Tobacco 5-epi-aristolochene synthase without buffer molecule in the active site”. X-ray diffraction, 7 pockets (best druggability 0.81). MolNFT v1 #122337 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5IM1
- Type
- protein
- Length
- 536 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 5-epi-aristolochene synthase
- EC
- 4.2.3.61
- UniProt
- Q40577
- Pockets
- 7 · best druggability 0.81
Structure
x-ray diffraction · 1 distinct chain · 71% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 5-epi-aristolochene synthase (EC 4.2.3.61) | protein | 536 | 71% helix, 0% strand | Q40577 |
Pockets
7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 554 | 0.81 | 0.87 | 51 | empty |
| 2 | 621 | 0.81 | 0.86 | 58 | empty |
| 3 | 338 | 0.58 | 0.76 | 30 | empty |
| 4 | 228 | 0.57 | 0.79 | 28 | empty |
| 5 | 97 | 0.50 | 0.82 | 15 | empty |
Compared structures
- 5IM1 · Tobacco 5-epi-aristolochene synthase without buffer molecule in the active site · the same entry in another collection · chain A against A, TM-score 1.00
- Q40577 · AlphaFold monomer V2.0 prediction for 5-epi-aristolochene synthase (Q40577) · a predicted model of the same protein · chain A against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q40577
- Elsewhere: RCSB PDB 5IM1 · PDBe 5IM1 · UniProt Q40577
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.